RAMIREZ, Pedro
Pedro RamirezDr. Pedro T. Ramirez is Professor in the Department of Gynecologic Oncology and Reproductive Medicine and Director of Minimally Invasive Surgical Research & Education. He is also the recipient of the David M. Gershenson Distinguished Professor in Ovarian Cancer Research Endowment and of the Randall Prize for Excellence in Cancer Treatment.
He has published a total of 234 manuscripts in peer-reviewed journals, including the New England Journal of Medicine and has published a total of 19 book chapters. In addition, he is the Editor for the textbook titled Principles of Gynecologic Oncology Surgery. Dr. Ramirez is also the Editor-in-Chief of the International Journal of Gynecological Cancer.
Dr. Ramirez is also the Chair of the Enhanced Recovery After Surgery (ERAS) Program in Gynecologic Oncology. He has published extensively on the subject of ERAS in numerable high-impact peer-reviewed journals. Of significant note, he co-authored the current Guidelines for ERAS Programs entitled “Guidelines for pre- and intraoperative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS) Society recommendations-Part I”, and “Guidelines for postoperative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS) Society recommendations-Part II”. These guidelines were published in the journal Gynecologic Oncology in 2016 and since their publication, they have been downloaded over 31,000 times. In addition, the most recent version of these ERAS Guidelines have been published in March 2019 in the International Journal of Gynecological Cancer and have been already downloaded 13,000 times.
Dr. Ramirez is the Principal Investigator in the LACC Trial: A Phase III Randomized Clinical Trial of Laparoscopic or Robotic Radical Hysterectomy versus Abdominal Radical Hysterectomy in Patients with Early Stage Cervical Cancer. The study accrued a total of 631 patients and was an international collaboration involving 33 sites throughout the world. This landmark study showed that minimally invasive radical hysterectomy in patients with early-stage cervical cancer was associated with a worse disease-free survival, recurrence rate, progression-free survival, and overall survival when compared to the open approach. These results have been practice changing and certainly will make an impact in the field of gynecologic oncology. The study was published in The New England Journal of Medicine in October 2018